Group T1 T2 T3 T4 T5
EXTEM C 51.8 ± 9.6 49.4 ± 10.1 45.3 ± 8.4* 43.8 ± 7.3* 41.8 ± 7.5*
R 52.9 ± 10.6 43.8 ± 9.5*# 44 ± 11.2* 43.9 ± 9.4* 42.8 ± 6.5*
INTEM C 45 ± 7.3 47.6 ± 5.1 42.7 ± 5.4* 41.6 ± 5.3* 42.7 ± 7.9
R 46.9 ± 9 41.1 ± 4.07*# 41.6 ± 4.3* 40.7 ± 6.8* 40.4 ± 6.4*
FIBTEM C 9.41 ± 1.6 9 ± 0.77 8.4 ± 1.01* 7.63 0.6* 7.3 ± 0.6*
R 9.16 ± 1.2 8.1 ± 0.86*# 7.9 ± 0.9* 7.53 0.52* 7.2 ± 0.7*
C, control group; R, rFVIIa group; T1, preoperative; T2, half an hour after the first dose; T3, half an hour after the second dose during the dissection phase; T4, after reperfusion and T5 at the end of surgery. * P<0.05 relative to preoperative value of the same group is considered statistically significant. #P<0.05 relative to the similar value of C group is considered statistically significant
Table 7: Maximum Clot Formation in millimeter (MCF) of Extrinsically (EXTEM), intrinsically (INTEM) and FIBTEM activated Thromboelastometry tests for both groups.